- not yet recruitingPHASE3
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
This study is testing a new medicine called Zenagamtide for people who have heart and blood vessel problems (like previous heart attack or stroke) and are also overweight or obese. It wants to see if Zenagamtide is safe and helps these patients better than a dummy medicine.
United States · Argentina · Australia - active not recruitingPHASE3
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
This study, called ARTEMIS, is testing a new medicine called ziltivekimab for people who have had a heart attack. It aims to see if ziltivekimab can prevent future heart problems compared to a dummy medicine.
United States · Argentina · Australia - not yet recruitingNA
Coffee Bioequivalence Trial
This study looks at whether coffee in a pill has the same effects on your body as drinking it. It also checks how both forms of coffee impact your heart and liver health. We're trying to make future large coffee studies simpler for participants.
United Kingdom - recruiting
Evaluation of the Clinical Benefit of the Aktiia Blood Pressure Monitoring for Early Awareness of Hypertension and Prediction of Cardiovascular Risk
This study looks at how a new type of blood pressure monitor (Aktiia G1) can help people with high blood pressure. It aims to see if continuous monitoring, combined with lifestyle information, can improve how we manage high blood pressure and predict heart health risks.
Switzerland · United Kingdom - active not recruitingPHASE3
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation
This study investigates if a new drug, ziltivekimab, can lower the risk of heart attacks and strokes in people with heart disease, kidney disease, and ongoing inflammation. Participants will receive either the drug or a dummy treatment to see if it makes a difference.
United States · Argentina · Australia - recruitingPHASE3
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
This study looks at a new diabetes drug, zenagamtide, compared to insulin glargine. It’s for people with type 2 diabetes who are already taking other diabetes medicines and are at a higher risk of heart and blood vessel problems. The aim is to see how well zenagamtide lowers blood sugar and body weight.
United States · Argentina · Brazil